Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Receivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Centessa Pharmaceuticals (CNTA) Total Current Liabilities: 2022-2025

Historic Total Current Liabilities for Centessa Pharmaceuticals (CNTA) over the last 4 years, with Sep 2025 value amounting to $29.1 million.

  • Centessa Pharmaceuticals' Total Current Liabilities rose 10.29% to $29.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $29.1 million, marking a year-over-year increase of 10.29%. This contributed to the annual value of $58.0 million for FY2024, which is 47.26% up from last year.
  • Centessa Pharmaceuticals' Total Current Liabilities amounted to $29.1 million in Q3 2025, which was down 1.93% from $29.7 million recorded in Q2 2025.
  • Centessa Pharmaceuticals' Total Current Liabilities' 5-year high stood at $58.0 million during Q4 2024, with a 5-year trough of $24.2 million in Q1 2025.
  • Over the past 3 years, Centessa Pharmaceuticals' median Total Current Liabilities value was $29.7 million (recorded in 2023), while the average stood at $32.7 million.
  • The largest annual percentage gain for Centessa Pharmaceuticals' Total Current Liabilities in the last 5 years was 47.26% (2024), contrasted with its biggest fall of 24.45% (2024).
  • Over the past 4 years, Centessa Pharmaceuticals' Total Current Liabilities (Quarterly) stood at $38.3 million in 2022, then rose by 2.73% to $39.4 million in 2023, then soared by 47.26% to $58.0 million in 2024, then climbed by 10.29% to $29.1 million in 2025.
  • Its Total Current Liabilities stands at $29.1 million for Q3 2025, versus $29.7 million for Q2 2025 and $24.2 million for Q1 2025.